Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 3
2018 2
2019 7
2020 8
2021 10
2022 20
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Tyrosine Kinase Receptors in Oncology.
Esteban-Villarrubia J, Soto-Castillo JJ, Pozas J, San Román-Gil M, Orejana-Martín I, Torres-Jiménez J, Carrato A, Alonso-Gordoa T, Molina-Cerrillo J. Esteban-Villarrubia J, et al. Among authors: molina cerrillo j. Int J Mol Sci. 2020 Nov 12;21(22):8529. doi: 10.3390/ijms21228529. Int J Mol Sci. 2020. PMID: 33198314 Free PMC article. Review.
In Reply.
Grande E, Molina-Cerrillo J, Alonso-Gordoa T. Grande E, et al. Among authors: molina cerrillo j. Oncologist. 2020 Aug;25(8):e1259. doi: 10.1634/theoncologist.2020-0336. Epub 2020 Jun 16. Oncologist. 2020. PMID: 32436340 Free PMC article.
Clinical surveillance in immunotherapy-treated patient.
Molina-Cerrillo J, Alonso-Gordoa T. Molina-Cerrillo J, et al. Med Clin (Barc). 2020 Jun 26;154(12):493-495. doi: 10.1016/j.medcli.2020.03.002. Epub 2020 Apr 13. Med Clin (Barc). 2020. PMID: 32299614 English, Spanish. No abstract available.
Novel Tyrosine Kinase Targets in Urothelial Carcinoma.
Torres-Jiménez J, Albarrán-Fernández V, Pozas J, Román-Gil MS, Esteban-Villarrubia J, Carrato A, Rosero A, Grande E, Alonso-Gordoa T, Molina-Cerrillo J. Torres-Jiménez J, et al. Among authors: molina cerrillo j. Int J Mol Sci. 2021 Jan 13;22(2):747. doi: 10.3390/ijms22020747. Int J Mol Sci. 2021. PMID: 33451055 Free PMC article. Review.
BRAF Mutated Colorectal Cancer: New Treatment Approaches.
Molina-Cerrillo J, San Román M, Pozas J, Alonso-Gordoa T, Pozas M, Conde E, Rosas M, Grande E, García-Bermejo ML, Carrato A. Molina-Cerrillo J, et al. Cancers (Basel). 2020 Jun 14;12(6):1571. doi: 10.3390/cancers12061571. Cancers (Basel). 2020. PMID: 32545884 Free PMC article. Review.
Epigenetics in advanced renal cell carcinoma: Potential new targets.
Molina-Cerrillo J, Santoni M, Ruiz Á, Massari F, Pozas J, Ortego I, Gómez V, Grande E, Alonso-Gordoa T. Molina-Cerrillo J, et al. Crit Rev Oncol Hematol. 2022 Dec;180:103857. doi: 10.1016/j.critrevonc.2022.103857. Epub 2022 Oct 17. Crit Rev Oncol Hematol. 2022. PMID: 36257538 Review.
Bronchial Carcinoids: From Molecular Background to Treatment Approach.
Araujo-Castro M, Pascual-Corrales E, Molina-Cerrillo J, Moreno Mata N, Alonso-Gordoa T. Araujo-Castro M, et al. Among authors: molina cerrillo j. Cancers (Basel). 2022 Jan 20;14(3):520. doi: 10.3390/cancers14030520. Cancers (Basel). 2022. PMID: 35158788 Free PMC article. Review.
Coming of Age of Immunotherapy of Urothelial Cancer.
Grande E, Molina-Cerrillo J, Necchi A. Grande E, et al. Among authors: molina cerrillo j. Target Oncol. 2021 May;16(3):283-294. doi: 10.1007/s11523-021-00804-7. Epub 2021 Mar 12. Target Oncol. 2021. PMID: 33710533 Review.
64 results